Evidence map›Paper›PMID 42908613›Full record

ArticleFrontiers in genetics2026

Duplication of the

Júlia Martinková, Hana Řezáčová, Alena Šantavá, Jana Drábová, Miroslav Štolfa, Radek Vodička, Jiřina Zapletalová, Miroslava Balaščaková, Anna Křepelová

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Júlia MartinkováDepartment of Biology and Medical Genetics, Second Faculty of Medicine, Charles University in Prague, Motol and Homolka University Hospital, Prague, Czechia.
Hana ŘezáčováDepartment of Biology and Medical Genetics, Second Faculty of Medicine, Charles University in Prague, Motol and Homolka University Hospital, Prague, Czechia.
Alena ŠantaváDepartment of Medical Genetics, University Hospital Olomouc, Olomouc, Czechia.
Jana DrábováDepartment of Biology and Medical Genetics, Second Faculty of Medicine, Charles University in Prague, Motol and Homolka University Hospital, Prague, Czechia.
Miroslav ŠtolfaDepartment of Biology and Medical Genetics, Second Faculty of Medicine, Charles University in Prague, Motol and Homolka University Hospital, Prague, Czechia.
Radek VodičkaDepartment of Medical Genetics, University Hospital Olomouc, Olomouc, Czechia.
Jiřina ZapletalováDepartment of Pediatrics, Faculty of Medicine, Palacky University and Olomouc University Hospital, Olomouc, Czechia.
Miroslava BalaščakováDepartment of Biology and Medical Genetics, Second Faculty of Medicine, Charles University in Prague, Motol and Homolka University Hospital, Prague, Czechia.
Anna KřepelováDepartment of Biology and Medical Genetics, Second Faculty of Medicine, Charles University in Prague, Motol and Homolka University Hospital, Prague, Czechia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

46,XX testicular disorder of sex development (DSD), also known as XX male syndrome, is a rare condition where an individual with a 46,XX karyotype develops a male phenotype. In 90% of cases, the syndrome results from the translocation of the

Indexed as

46,XX male syndrome46,XX testicular DSDdisorders of sex developmentDSDSOX3 duplicationSRY-negative

Identifiers

PMID42908613
PMCPMC13683180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.